icon
body
VYNDAMAX is used to treat adults with wild-type or hereditary ATTR-CM to reduce death and hospitalization related to heart problems.
name
link
dismiss
false
image
Older patient and caregiver signing up for Vyndacares, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.
mobile_image
Older patient and caregiver signing up for Vyndacares, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.
eyebrow
headline

Sign up for VyndaCares™

content
buttons
disclaimer
image
Vyndacares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.
image_mobile
Vyndacares logo, a program that provides helpful information about ATTR-CM and VYNDAMAX (tafamidis). See safety info.
Image_disclaimer
eyebrow
headline

Get to the heart of what to know about transthyretin cardiac amyloidosis (ATTR-CM) and VYNDAMAX

headline2

Once you sign up, you’ll receive educational materials throughout your treatment journey. Topics may include:

content
  • Understanding ATTR-CM and how it can impact your body and life
  • Learning how VYNDAMAX works and how it can help slow the progression of ATTR-CM
  • Hearing real patient stories, where people discuss topics like ATTR-CM diagnosis, treatment experience, and more
  • Exploring information about financial assistance and insurance benefits
  • Accessing support, tips, tools, and other helpful resources throughout your treatment
content2
buttons
Cta_brightcove_account_id
Cta_brightcove_video_id
disclaimer
token
form_builder__production__2184__wd
success_page
../signup-thank-you
success_redirect
TRUE
staging_active
TRUE
form_name
signup